LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | HG-5-88-01 | 10 | uM | LJP6 | 2 | A19 | 72 | hr | 1334 | 2602 | 3899 | 0.6673 | 0.5398 |
| BT-20 | HG-5-88-01 | 10 | uM | LJP6 | 3 | A19 | 72 | hr | 1334 | 2387 | 3921 | 0.6087 | 0.4534 |
| BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 1 | M06 | 72 | hr | 1334 | 4264 | 3955 | 1.0779 | 1.0981 |
| BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 1334 | 4471 | 3899 | 1.1467 | 1.1850 |
| BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 1334 | 4264 | 3921 | 1.0874 | 1.1107 |
| BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 1 | M05 | 72 | hr | 1334 | 3899 | 3955 | 0.9856 | 0.9816 |
| BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 1334 | 4270 | 3899 | 1.0951 | 1.1210 |
| BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 1334 | 4204 | 3921 | 1.0721 | 1.0916 |
| BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 1 | M04 | 72 | hr | 1334 | 4637 | 3955 | 1.1722 | 1.2134 |
| BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 2 | M04 | 72 | hr | 1334 | 3981 | 3899 | 1.0210 | 1.0270 |
| BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 3 | M04 | 72 | hr | 1334 | 3868 | 3921 | 0.9864 | 0.9825 |
| BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1334 | 3305 | 3955 | 0.8355 | 0.7833 |
| BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1334 | 3465 | 3899 | 0.8887 | 0.8530 |
| BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1334 | 3233 | 3921 | 0.8245 | 0.7665 |
| BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 1334 | 1856 | 3955 | 0.4692 | 0.2341 |
| BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 1334 | 2256 | 3899 | 0.5786 | 0.4041 |
| BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 1334 | 2356 | 3921 | 0.6008 | 0.4412 |
| BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 1 | M01 | 72 | hr | 1334 | 786 | 3955 | 0.1987 | -0.2867 |
| BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 2 | M01 | 72 | hr | 1334 | 1912 | 3899 | 0.4904 | 0.2616 |
| BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 3 | M01 | 72 | hr | 1334 | 1728 | 3921 | 0.4407 | 0.1807 |
| BT-20 | Neratinib | 0.04 | uM | LJP5 | 1 | A18 | 72 | hr | 1334 | 2822 | 3930 | 0.7179 | 0.6169 |
| BT-20 | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 1334 | 3157 | 4051 | 0.7793 | 0.7117 |
| BT-20 | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 1334 | 3326 | 4117 | 0.8077 | 0.7538 |
| BT-20 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1334 | 2820 | 3930 | 0.7174 | 0.6161 |
| BT-20 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 1334 | 2879 | 4051 | 0.7107 | 0.6160 |